BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36796126)

  • 21. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma.
    Oh HN; Oh KB; Lee MH; Seo JH; Kim E; Yoon G; Cho SS; Cho YS; Choi HW; Chae JI; Shim JH
    Phytomedicine; 2019 Jan; 52():60-69. PubMed ID: 30599913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenethyl isothiocyanate induces DNA damage-associated G2/M arrest and subsequent apoptosis in oral cancer cells with varying p53 mutations.
    Yeh YT; Yeh H; Su SH; Lin JS; Lee KJ; Shyu HW; Chen ZF; Huang SY; Su SJ
    Free Radic Biol Med; 2014 Sep; 74():1-13. PubMed ID: 24952138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetylshikonin inhibits growth of oral squamous cell carcinoma by inducing apoptosis.
    Kim DJ; Lee JH; Park HR; Choi YW
    Arch Oral Biol; 2016 Oct; 70():149-157. PubMed ID: 27371806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of verbascoside on apoptosis and metastasis in human oral squamous cell carcinoma.
    Zhang Y; Yuan Y; Wu H; Xie Z; Wu Y; Song X; Wang J; Shu W; Xu J; Liu B; Wan L; Yan Y; Ding X; Shi X; Pan Y; Li X; Yang J; Zhao X; Wang L
    Int J Cancer; 2018 Aug; 143(4):980-991. PubMed ID: 29536537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of JMJD5 suppresses metastasis and induces apoptosis in oral squamous cell carcinoma by regulating p53/NF-κB pathway.
    Yao Y; Zhou WY; He RX
    Biomed Pharmacother; 2019 Jan; 109():1994-2004. PubMed ID: 30551455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanism of inhibitory effects of bovine lactoferrin on the growth of oral squamous cell carcinoma.
    Chea C; Miyauchi M; Inubushi T; Febriyanti Ayuningtyas N; Subarnbhesaj A; Nguyen PT; Shrestha M; Haing S; Ohta K; Takata T
    PLoS One; 2018; 13(1):e0191683. PubMed ID: 29381751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
    Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
    BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. San-Zhong-Kui-Jian-Tang Exerts Antitumor Effects Associated With Decreased Cell Proliferation and Metastasis by Targeting ERK and the Epithelial-Mesenchymal Transition Pathway in Oral Cavity Squamous Cell Carcinoma.
    Hsu PY; Chen JL; Kuo SL; Wang WL; Jan FW; Yang SH; Yang CY
    Integr Cancer Ther; 2022; 21():15347354221134921. PubMed ID: 36404765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chrysophanol-Induced Autophagy Disrupts Apoptosis via the PI3K/Akt/mTOR Pathway in Oral Squamous Cell Carcinoma Cells.
    Park DB; Park BS; Kang HM; Kim JH; Kim IR
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676666
    [No Abstract]   [Full Text] [Related]  

  • 30. The promoting effect of neutrophil-derived BAFF molecule on the proliferation and life span of CAL-27 oral squamous carcinoma cells.
    Jablonska E; Iwaniuk A; Ratajczak-Wrona W; Grubczak K; Dziemianczyk-Pakiela D; Moniuszko M; Nowak K; Borys J; Garley M
    Immunobiology; 2022 Sep; 227(5):152247. PubMed ID: 35933760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma.
    Johnson JJ; Miller DL; Jiang R; Liu Y; Shi Z; Tarwater L; Williams R; Balsara R; Sauter ER; Stack MS
    J Biol Chem; 2016 Mar; 291(13):6936-45. PubMed ID: 26839311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo.
    Chen S; Hu H; Miao S; Zheng J; Xie Z; Zhao H
    Tumour Biol; 2017 May; 39(5):1010428317705330. PubMed ID: 28513299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Network-Based Method to Investigate the Promoted Cell Apoptosis Mechanisms of Oridonin in OSCC through the RNA-Transcriptome.
    Wu G; Guo Y; Liu Y; Cai X; Deng T; Pei T; Huang L; Chen K; Pan X
    J Immunol Res; 2023; 2023():5293677. PubMed ID: 36969496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticancer activity of pyrithione zinc in oral cancer cells identified in small molecule screens and xenograft model: Implications for oral cancer therapy.
    Srivastava G; Matta A; Fu G; Somasundaram RT; Datti A; Walfish PG; Ralhan R
    Mol Oncol; 2015 Oct; 9(8):1720-35. PubMed ID: 26115765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cantharidin Induced Oral Squamous Cell Carcinoma Cell Apoptosis via the JNK-Regulated Mitochondria and Endoplasmic Reticulum Stress-Related Signaling Pathways.
    Su CC; Lee KI; Chen MK; Kuo CY; Tang CH; Liu SH
    PLoS One; 2016; 11(12):e0168095. PubMed ID: 27930712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma.
    Wang H; Zhu L; Feng X; Zhang H; Luo Q; Chen F
    Eur J Pharmacol; 2017 Nov; 815():282-289. PubMed ID: 28935563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide inhibits proliferation, migration and invasion in oral squamous cell carcinoma cells.
    Li X; Ding R; Han Z; Ma Z; Wang Y
    Biomed Pharmacother; 2017 Dec; 96():434-442. PubMed ID: 29031202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Astaxanthin inhibits hallmarks of cancer by targeting the PI3K/NF-κΒ/STAT3 signalling axis in oral squamous cell carcinoma models.
    Kowshik J; Nivetha R; Ranjani S; Venkatesan P; Selvamuthukumar S; Veeravarmal V; Nagini S
    IUBMB Life; 2019 Oct; 71(10):1595-1610. PubMed ID: 31251469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chloroform Extract of Solanum lyratum Induced G0/G1 Arrest via p21/p16 and Induced Apoptosis via Reactive Oxygen Species, Caspases and Mitochondrial Pathways in Human Oral Cancer Cell Lines.
    Chiu CH; Chou YC; Lin JP; Kuo CL; Lu HF; Huang YP; Yu CC; Lin ML; Chung JG
    Am J Chin Med; 2015; 43(7):1453-69. PubMed ID: 26477797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of Histone Deacetylase Inhibitor Sensitivity in Combination with Cyclin-Dependent Kinase Inhibition for the Treatment of Oral Squamous Cell Carcinoma.
    Zhao B; Huang Z; Qin Z; Li Y; Wang T; Wang L; Zhou W; Yu C; Wang X; Yang S; Fan Y; Xiang R
    Cell Physiol Biochem; 2019; 53(1):141-156. PubMed ID: 31237760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.